The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Risk for Death Associated with Medications for Recently Diagnosed Chronic Obstructive Pulmonary Disease
Abstract
BACKGROUND: Concerns exist regarding increased risk for mortality associated with some chronic obstructive pulmonary disease (COPD) medications. OBJECTIVE: To examine the association between various respiratory medications and risk for death in veterans with newly diagnosed COPD. DESIGN: Nested case-control study in a cohort identified between 1 October 1999 and 30 September 2003 and followed through 30 September 2004 by using National Veterans Affairs inpatient, outpatient, pharmacy, and mortality databases; Centers for Medicare & Medicaid Services databases; and National Death Index Plus data. Cause of death was ascertained for a random sample of 40% of those who died during follow-up. Case patients were categorized on the basis of all-cause, respiratory, or cardiovascular death. Mortality risk associated with medications was assessed by using conditional logistic regression adjusted for comorbid conditions, health care use, and markers of COPD severity. SETTING: U.S. Veterans Health Administration health care system. PARTICIPANTS: 32 130 case patients and 320 501 control participants in the all-cause mortality analysis. Of 11 897 patients with cause-of-death data, 2405 case patients had respiratory deaths and 3159 case patients had cardiovascular deaths. MEASUREMENTS: All-cause mortality; respiratory and cardiovascular deaths; and exposure to COPD medications, inhaled corticosteroids, ipratropium, long-acting beta-agonists, and theophylline in the 6 months preceding death. RESULTS: Adjusted odds ratios (ORs) for all-cause mortality were 0.80 (95% CI, 0.78 to 0.83) for inhaled corticosteroids, 1.11 (CI, 1.08 to 1.15) for ipratropium, 0.92 (CI, 0.88 to 0.96) for long-acting beta-agonists, and 1.05 (CI, 0.99 to 1.10) for theophylline. Ipratropium was associated with increased cardiovascular deaths (OR, 1.34 [CI, 1.22 to 1.47]), whereas inhaled corticosteroids were associated with reduced risk for cardiovascular death (OR, 0.80 [CI, 0.72 to 0.88]). Results were consistent across sensitivity analyses. LIMITATIONS: Current smoking status and lung function were not measured. Misclassification of cause-specific mortality is unknown. CONCLUSION: The possible association between ipratropium and elevated risk for all-cause and cardiovascular death needs further study.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study
Murray, C. J., & Lopez, A. D. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07495-8 · Cited by 4,492 · cited 1×
“Chronic obstructive pulmonary disease (COPD) is associated with substantial burden in terms of prevalence of disease (1), death and disability risk (2, 3), and health care costs (4).”
BackgroundModeling and variable selection in epidemiologic analysis
Greenland, S. (1989) · American Journal of Public Health · doi:10.2105/ajph.79.3.340 · Cited by 2,208
Mannino, D. M. (2003) · Thorax · doi:10.1136/thorax.58.5.388 · Cited by 639
Using the National Death Index to obtain underlying cause of death codes.
Sathiakumar, N., Delzell, E., & Abdalla, O. (1998) · Journal of Occupational & Environmental Medicine · doi:10.1097/00043764-199809000-00010 · Cited by 109
Doody, M. M., Hayes, H. M., & Bilgrad, R. (2001) · Annals of Epidemiology · doi:10.1016/s1047-2797(00)00177-0 · Cited by 79 · cited 1×
“We used National Death Index Plus data to identify cause of death, which has shown high concordance with coding by trained nosologists but may not be consistent with adjudicated deaths in clinical trials (35, 36).”
Method
Cited by
Pharmacology and Therapeutics of Bronchodilators
Cazzola, M., Page, C. P., Calzetta, L., & Matera, M. G. (2012) · Pharmacological Reviews · doi:10.1124/pr.111.004580 · Cited by 467
Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity
Finkelstein, J., Cha, E., & Scharf, S. (2009) · International Journal of Chronic Obstructive Pulmonary Disease · doi:10.2147/copd.s6400 · Cited by 267
Gershon, A. S., Campitelli, M. A., Croxford, R., Stanbrook, M. B., To, T., Upshur, R., Stephenson, A. L., & Stukel, T. A. (2014) · JAMA · doi:10.1001/jama.2014.11432 · Cited by 121
Metadata
- Authors
- Lee, T. A., Pickard, A. S., Au, D. H., Bartle, B., & Weiss, K. B.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2008-09-16
- Volume
- 149
- Issue
- 6
- Pages
- 380-390
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2016274438
- Cited by
- 170
- References
- 5
- FWCI
- 23.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Risk for Death Associated with Medications for Recently Diagnosed Chronic Obstructive Pulmonary Disease. https://app.cochat.ai/papers/10.7326/0003-4819-149-6-200809160-00004
- The paper
- Lee, T. A., Pickard, A. S., Au, D. H., Bartle, B., & Weiss, K. B. (2008). Risk for Death Associated with Medications for Recently Diagnosed Chronic Obstructive Pulmonary Disease. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-149-6-200809160-00004
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.